Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|September 20, 2014
Human endotoxin administration as an experimental model in drug developmentA F Suffredini, R J NoveckSchweizerische Medizinische Wochenschrift|October 30, 1998
Myocardial dysfunction in sepsis: clinical and experimental investigationsA F SuffrediniCritical Care Medicine|July 1, 1994
Current prospects for the treatment of clinical sepsisA F SuffrediniJournal of Endotoxin Research|December 26, 2001
Human models of innate immunity: local and systemic inflammatory responsesC Fiuza, A F SuffrediniThrombosis and Haemostasis|December 29, 1984
Inhibition of platelet production induced by an antiplatelet drug, anagrelide, in normal volunteersW Abe Andes, R J Noveck, J S FlemingNeuroimmunomodulation|September 1, 1995
Endotoxin causes release of alpha-melanocyte-stimulating hormone in normal human subjectsA Catania, A F Suffredini, J M LiptonThe Journal of Infectious Diseases|April 7, 1999
Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxinA F Suffredini, H D Hochstein, F G McMahonThe New England Journal of Medicine|May 4, 1989
Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjectsA F Suffredini, P C Harpel, J E ParrilloAmerican Heart Journal|July 1, 1983
Extrarenal contributions to indapamide's antihypertensive mechanism of actionR J Noveck, F G McMahon, A Quiros, et al.Pageof 7